T-reg depleted DLI

DRUG2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris

Conditions

Hematological MalignanciesRegulatory T Cell DepletionRelapse

Phase 1

Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion

Not yet recruitingNCT06180499

Assistance Publique - Hôpitaux de ParisHematological Malignancies, Regulatory T Cell Depletion, Relapse

Start: 2024-03-31End: 2029-09-30Target: 27Updated: 2024-02-14

Phase 3

Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells

RecruitingNCT03236129

Assistance Publique - Hôpitaux de ParisHematological Malignancies, Regulatory T Cell Depletion, Relapse

Start: 2018-02-22End: 2026-02-28Target: 52Updated: 2023-12-18